Outcomes are better for those who work with ... include trospium, darifenacin, and oxybutynin, available for women as an over ...

and trospium chloride, did not significantly increase the risk of dementia. The research specifically focused on long-term treatments for overactive bladder commonly prescribed in clinical practice.